OBJECTIVES: To test whether overweight or obese employees who achieve clinically significant weight loss of ≥ 5% have reduced medical expenditures, absenteeism, presenteeism, and/or improved Health-Related Quality Of Life (HRQOL). METHODS: The sample analyzed combines data from full-time overweight or obese employees who took part in one of the WAY to Health weight loss studies: 1 that took place in 17 community colleges (935 employees) and another in 12 universities (933), all in North Carolina. The estimations are performed using nonlinear difference-in-difference models where groups are identified by whether the employee achieved a ≥ 5% weight loss (treated) or not (control) and the treatment variable indicates preweight and postweight loss intervention. The outcomes analyzed are the average quarterly (90 d) amount of medical claims paid by the health insurer, number of days missed at work during the past month, Stanford Presenteeism Scale SPS-6, and the EQ-5D-3L measure of HRQOL. RESULTS: We find statistical evidence supporting that ≥ 5% weight loss prevents deterioration in EQ-5D-3L scores by 0.026 points (P-value=0.03) and reduces both absenteeism by 0.258 d/mo (P-value=0.093) and the likelihood of showing low presenteeism (Stanford SPS-6 score between 7 and 9) by 2.9 percentage points (P-value=0.083). No reduction in medical expenditures was observed. CONCLUSIONS: Clinically significant weight loss among overweight or obese employees prevents short-term deterioration in HRQOL and there is some evidence that employee productivity is increased. We find no evidence of a quick return on investment from reduced medical expenditures, although this may occur over longer periods.
OBJECTIVES: To test whether overweight or obese employees who achieve clinically significant weight loss of ≥ 5% have reduced medical expenditures, absenteeism, presenteeism, and/or improved Health-Related Quality Of Life (HRQOL). METHODS: The sample analyzed combines data from full-time overweight or obese employees who took part in one of the WAY to Health weight loss studies: 1 that took place in 17 community colleges (935 employees) and another in 12 universities (933), all in North Carolina. The estimations are performed using nonlinear difference-in-difference models where groups are identified by whether the employee achieved a ≥ 5% weight loss (treated) or not (control) and the treatment variable indicates preweight and postweight loss intervention. The outcomes analyzed are the average quarterly (90 d) amount of medical claims paid by the health insurer, number of days missed at work during the past month, Stanford Presenteeism Scale SPS-6, and the EQ-5D-3L measure of HRQOL. RESULTS: We find statistical evidence supporting that ≥ 5% weight loss prevents deterioration in EQ-5D-3L scores by 0.026 points (P-value=0.03) and reduces both absenteeism by 0.258 d/mo (P-value=0.093) and the likelihood of showing low presenteeism (Stanford SPS-6 score between 7 and 9) by 2.9 percentage points (P-value=0.083). No reduction in medical expenditures was observed. CONCLUSIONS: Clinically significant weight loss among overweight or obese employees prevents short-term deterioration in HRQOL and there is some evidence that employee productivity is increased. We find no evidence of a quick return on investment from reduced medical expenditures, although this may occur over longer periods.
Authors: Cheryl Koopman; Kenneth R Pelletier; James F Murray; Claire E Sharda; Marc L Berger; Robin S Turpin; Paul Hackleman; Pamela Gibson; Danielle M Holmes; Talor Bendel Journal: J Occup Environ Med Date: 2002-01 Impact factor: 2.162
Authors: Ron Z Goetzel; Teresa B Gibson; Meghan E Short; Bong-Chul Chu; Jessica Waddell; Jennie Bowen; Stephenie C Lemon; Isabel Diana Fernandez; Ronald J Ozminkowski; Mark G Wilson; David M DeJoy Journal: J Occup Environ Med Date: 2010-01 Impact factor: 2.162
Authors: S Bryn Austin; Allegra R Gordon; Najat J Ziyadeh; Brittany M Charlton; Sabra L Katz-Wise; Mihail Samnaliev Journal: Am J Prev Med Date: 2017-07-28 Impact factor: 5.043
Authors: Sagun Agrawal; Alexis C Wojtanowski; Laura Tringali; Gary D Foster; Eric A Finkelstein Journal: PLoS One Date: 2021-02-11 Impact factor: 3.240
Authors: Kirthi Menon; Barbora de Courten; Zanfina Ademi; Alice J Owen; Danny Liew; Ella Zomer Journal: Int J Obes (Lond) Date: 2022-05-11 Impact factor: 5.551
Authors: Brittany M Charlton; Allegra R Gordon; Sari L Reisner; Vishnudas Sarda; Mihail Samnaliev; S Bryn Austin Journal: BMJ Open Date: 2018-07-26 Impact factor: 2.692